These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29917221)

  • 1. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
    Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
    Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
    Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
    Wong E; Juneja S
    Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.
    Goasguen JE; Bennett JM; Bain BJ; Brunning RD; Vallespí MT; Tomonaga M; Zini G; Renault A;
    Leuk Res; 2016 Jun; 45():75-81. PubMed ID: 27107657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
    Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
    Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
    Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
    Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
    Bennett JM
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.
    Malcovati L; Cazzola M
    Br J Haematol; 2016 Sep; 174(6):847-58. PubMed ID: 27391606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
    Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
    Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspected myelodysplastic/myeloproliferative neoplasm in a feline leukemia virus-negative cat.
    Weeden AL; Taylor KR; Terrell SP; Gallagher AE; Wamsley HL
    Vet Clin Pathol; 2016 Dec; 45(4):584-593. PubMed ID: 27870069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome.
    Gupta R; Abdalla SH; Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):615-9. PubMed ID: 10492088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
    Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
    Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.